SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
HEADROOM APPROACH TO DEVICE DEVELOPMENT: CURRENT AND FUTURE DIRECTIONS
16 references·0 citing·46 second hop
HEADROOM APPROACH TO DEVICE DEVELOPMENT: CURRENT AND FUTURE DIRECTIONS (2015)HEADROOM APPROACH TO DEVICE DEVELOPMENT: …CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS? (2014)CAUSES FOR CONCERN: IS NICE F…Early Assessment of Medical Technologies to Inform Product Development and Market Access (2011)Early Assessment of Medical T…Evaluating policy and service interventions: framework to guide selection and interpretation of study end points (2010)Evaluating policy and service…Early-Stage Valuation of Medical Devices: The Role of Developmental Uncertainty (2010)Early-Stage Valuation of Medi…Integrating health economics modeling in the product development cycle of medical devices: A Bayesian approach (2008)Integrating health economics …Contribution of economic evaluation to decision making in early phases of product development: A methodological and empirical review (2008)Contribution of economic eval…OFT, VBP: QED? (2007)OFT, VBP: QED?Investing in new medical technologies: A decision framework (2007)Investing in new medical tech…Cost-effectiveness analysis at the development phase of a potential health technology: examples based on tissue engineering of bladder and urethra (2007)Cost-effectiveness analysis a…Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems) (2006)Framework for describing and …Expected Value of Sample Information Calculations in Medical Decision Modeling (2004)Expected Value of Sample Info…The development of health technology assessment (2003)The development of health tec…Real options analysis : tools and techniques for valuing strategic investments and decisions (2002)Real options analysis : tools…The Iterative Use of Economic Evaluation as Part of the Process of Health Technology Assessment (1997)The Iterative Use of Economic…Investment Under Uncertainty. (1994)Investment Under Uncertainty.Investment under Uncertainty (1994)Investment under UncertaintyAccounting for future costs in medical cost-effectiveness analysis (1997)Value based pricing for NHS drugs: an opportunity not to be missed? (2008)The Influence of Cost‐Effectiveness and Other Factors on Nice Decisions (2014)Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding Decisions (2017)Implementation of Value-based Pricing for Medicines (2019)Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000–20: a retrospective analysis (2024)Publication Bias: The Problem That Won't Go Away (1993)Inter-rater reliability of case-note audit: a systematic review (2007)Challenges, solutions and future directions in the evaluation of service innovations in health care and public health (2016)Improving the health and welfare of people who live in slums (2016)Assessment of publication bias and outcome reporting bias in systematic reviews of health services and delivery research: A meta-epidemiological study (2020)Effectiveness and Efficiency (1994)Cochrane Collaboration Handbook (1996)Patient-based health technology assessment: A vision of the future (2007)The New Industrial State (2007)Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up? (2010)Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries (2017)Meta-analysis in clinical trials (1986)Markov Models in Medical Decision Making (1993)Explaining heterogeneity in meta-analysis: a comparison of methods (1999)The Interpretation of Random-Effects Meta-Analysis in Decision Models (2005)Using Value of Information Analysis to Prioritise Health Research (2006)Estimating Multiparameter Partial Expected Value of Perfect Information from a Probabilistic Sensitivity Analysis Sample (2013)Statistical Decision Theory (1989)Net Health Benefits (1998)Dangerous omissions: the consequences of ignoring decision uncertainty (2010)Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment (2016)Twenty years of network meta‐analysis: Continuing controversies and recent developments (2024)The analytic hierarchy process : planning, priority setting, resource allocation (1980)The price of innovation: new estimates of drug development costs (2003)Beyond high tech: early adopters of open innovation in other industries (2006)The Economic Evaluation of Medical Devices (2013)MEDICAL DEVICES EARLY ASSESSMENT METHODS: SYSTEMATIC LITERATURE REVIEW (2014)Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA) (2015)Clinical Decision Analysis (1980)Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis (1994)Clinical decision analysis (2005)When and how to update systematic reviews: consensus and checklist (2016)Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature (2017)Value of Information Analysis for Research Decisions—An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force (2020)A real options evaluation model for the diffusion prospects of new renewable power generation technologies (2006)Enabling Flexibility in Engineering Systems: A Taxonomy of Procedures and a Design Framework (2013)The Impact of Uncertainty Shocks (2009)Policy Uncertainty and Corporate Investment (2015)Measuring Economic Policy Uncertainty* (2016)Capital markets research in accounting (2001)
this work references cited by second hop

References

  • 1994Investment Under Uncertainty.9,566 cited
  • 1994Investment under Uncertainty9,092 cited
  • 2002Real options analysis : tools and techniques for valuing strategic investments and decisions484 cited
  • 2004Expected Value of Sample Information Calculations in Medical Decision Modeling365 cited
  • 2003The development of health technology assessment334 cited
  • 1997The Iterative Use of Economic Evaluation as Part of the Process of Health Technology Assessment208 cited
  • 2011Early Assessment of Medical Technologies to Inform Product Development and Market Access188 cited
  • 2010Evaluating policy and service interventions: framework to guide selection and interpretation of study end points146 cited
  • 2014CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS?114 cited
  • 2007OFT, VBP: QED?114 cited
  • 2006Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems)101 cited
  • 2008Integrating health economics modeling in the product development cycle of medical devices: A Bayesian approach93 cited
  • 2008Contribution of economic evaluation to decision making in early phases of product development: A methodological and empirical review92 cited
  • 2007Investing in new medical technologies: A decision framework

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

86 cited
  • 2007Cost-effectiveness analysis at the development phase of a potential health technology: examples based on tissue engineering of bladder and urethra77 cited
  • 2010Early-Stage Valuation of Medical Devices: The Role of Developmental Uncertainty54 cited
  • Cited by

    No citing works inside the corpus for this window.